1. Home
  2. ASPN vs DAWN Comparison

ASPN vs DAWN Comparison

Compare ASPN & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASPN
  • DAWN
  • Stock Information
  • Founded
  • ASPN 2001
  • DAWN 2018
  • Country
  • ASPN United States
  • DAWN United States
  • Employees
  • ASPN N/A
  • DAWN N/A
  • Industry
  • ASPN RETAIL: Building Materials
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASPN Consumer Discretionary
  • DAWN Health Care
  • Exchange
  • ASPN Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • ASPN 573.2M
  • DAWN 624.8M
  • IPO Year
  • ASPN 2014
  • DAWN 2021
  • Fundamental
  • Price
  • ASPN $7.74
  • DAWN $7.31
  • Analyst Decision
  • ASPN Buy
  • DAWN Strong Buy
  • Analyst Count
  • ASPN 6
  • DAWN 7
  • Target Price
  • ASPN $14.40
  • DAWN $27.86
  • AVG Volume (30 Days)
  • ASPN 2.0M
  • DAWN 1.3M
  • Earning Date
  • ASPN 11-06-2025
  • DAWN 11-04-2025
  • Dividend Yield
  • ASPN N/A
  • DAWN N/A
  • EPS Growth
  • ASPN N/A
  • DAWN N/A
  • EPS
  • ASPN N/A
  • DAWN N/A
  • Revenue
  • ASPN $397,175,000.00
  • DAWN $187,638,000.00
  • Revenue This Year
  • ASPN N/A
  • DAWN $12.88
  • Revenue Next Year
  • ASPN $8.56
  • DAWN $48.27
  • P/E Ratio
  • ASPN N/A
  • DAWN N/A
  • Revenue Growth
  • ASPN 11.18
  • DAWN 2190.50
  • 52 Week Low
  • ASPN $4.16
  • DAWN $5.64
  • 52 Week High
  • ASPN $18.95
  • DAWN $16.76
  • Technical
  • Relative Strength Index (RSI)
  • ASPN 48.75
  • DAWN 50.46
  • Support Level
  • ASPN $7.52
  • DAWN $6.90
  • Resistance Level
  • ASPN $8.56
  • DAWN $7.86
  • Average True Range (ATR)
  • ASPN 0.48
  • DAWN 0.41
  • MACD
  • ASPN -0.08
  • DAWN -0.03
  • Stochastic Oscillator
  • ASPN 12.04
  • DAWN 34.17

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: